Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I Clinical Study of BVX-0918A for Late-Stage Ovarian Cancer in Spain

Trial Profile

A Phase I Clinical Study of BVX-0918A for Late-Stage Ovarian Cancer in Spain

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 06 Dec 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BVX-0918A (Primary)
  • Indications Ovarian cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Dec 2022 According to a BioVaxys media release, company has completed the clinical study protocol, and EU clinical development and marketing partner, Procare Health Iberia, has selected a CRO and already begun meeting with prospective Spanish Phase I study investigators
    • 18 May 2022 According to a BioVaxys media release, Hospices Civils de Lyon, France (HCL) has agreed to serve as a clinical study site for this Phase I study of BVX-0918, BioVaxys is preparing to file a Clinical Trial Application with the European Medicines Agency later in 2022.
    • 25 Apr 2022 According to a BioVaxys media release, this study expected to begin later this year.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top